High-dose chemotherapy for Ewing sarcoma and Rhabdomyosarcoma: A systematic review by the Australia and New Zealand sarcoma association clinical practice guidelines working party.
- DOI
- 10.1016/j.ctrv.2024.102694
- Published
- 2024 Mar
- Container
- Cancer treatment reviews
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.ctrv.2024.102694,
title = {High-dose chemotherapy for Ewing sarcoma and Rhabdomyosarcoma: A systematic review by the Australia and New Zealand sarcoma association clinical practice guidelines working party.},
author = {Ramamurthy A and Connolly EA and Mar J and Lewin J and Bhadri VA and Phillips MB and Winstanley M and Orme LM and Grimison P and Connor J and Lazarakis S and Hong AM and Omer N and Cayrol J},
year = {2024},
journal = {Cancer treatment reviews},
doi = {10.1016/j.ctrv.2024.102694},
url = {https://doi.org/10.1016/j.ctrv.2024.102694}
}RIS
TY - JOUR TI - High-dose chemotherapy for Ewing sarcoma and Rhabdomyosarcoma: A systematic review by the Australia and New Zealand sarcoma association clinical practice guidelines working party. AU - Ramamurthy A AU - Connolly EA AU - Mar J AU - Lewin J AU - Bhadri VA AU - Phillips MB AU - Winstanley M AU - Orme LM AU - Grimison P AU - Connor J AU - Lazarakis S AU - Hong AM AU - Omer N AU - Cayrol J PY - 2024 JO - Cancer treatment reviews DO - 10.1016/j.ctrv.2024.102694 UR - https://doi.org/10.1016/j.ctrv.2024.102694 ER -
APA
A, R., EA, C., J, M., J, L., VA, B., MB, P., M, W., LM, O., P, G., J, C., S, L., AM, H., N, O., & J, C. (2024). High-dose chemotherapy for Ewing sarcoma and Rhabdomyosarcoma: A systematic review by the Australia and New Zealand sarcoma association clinical practice guidelines working party.. Cancer treatment reviews. https://doi.org/10.1016/j.ctrv.2024.102694
Source records
- pubmed · retrieved 2026-09-25T06:37:53.252Z